Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Haaris Mir

Plastic and Reconstructive Surgery Miami, FL Medical Doctor

NPI 1285827337 CMS profile 148953

11750 Bird Rd, Miami, FL 33175

Open in the dashboard

General payments

$24,322

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$28,989 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Haaris Mir of Miami, FL is reported in the CMS Open Payments database as having received $24,322 across 84 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $28,989 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $997 17
2024 General $7,399 23
2023 General $6,861 14
2022 General $6,221 13
2021 General $544 5
2020 General $936 4
2019 General $1,364 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Haaris Mir
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Haaris Mir were reported at $997. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Haaris Mir Plastic and Reconstructive Surgery median Middle half National median
2019 $1,364 $335 $121–$1,264 $163
2020 $936 $162 $57–$417 $114
2021 $544 $245 $89–$735 $132
2022 $6,221 $325 $120–$932 $149
2023 $6,861 $343 $129–$999 $160
2024 $7,399 $390 $141–$1,085 $164
2025 $997 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $11,937 7 payments
  2. Smith+Nephew, Inc. $8,379 36 payments
  3. KCI USA, Inc $1,747 5 payments
  4. Avita Medical Americas, LLC $516 9 payments
  5. Integra LifeSciences Corporation $472 5 payments
  6. Stryker Corporation $225 2 payments
  7. Aroa Biosurgery Incorporated $224 1 payment
  8. AxoGen $115 2 payments
  9. Zimmer Biomet Holdings, Inc. $109 1 payment
  10. PolarityTE, Inc. $100 1 payment
  11. Other $499 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $10,494 6 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $5,000 1 payment
  3. Food and Beverage $4,014 72 payments
  4. Travel and Lodging $3,468 3 payments
  5. Education $1,250 1 payment
  6. Entertainment $97 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose Wound Care $11,937 7 payments
  2. Kerecis Omega3 GraftGuide $11,853 6 payments
  3. Versajet $7,202 11 payments
  4. Kerecis Omega3 SurgiClose Wound Care $6,332 3 payments
  5. Kerecis Omega3 Marigen Wound Care $6,332 3 payments
  6. Kerecis Omega3 SurgiClose Wound Care $6,332 3 payments
  7. Kerecis Omega3 Marigen Wound Care $5,605 4 payments
  8. Kerecis Omega3 Marigen Wound Care $5,521 3 payments
  9. Kerecis Omega3 Marigen Wound Care $5,521 3 payments
  10. OASIS $1,266 23 payments
  11. Other $8,127 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$276,411

Medicare's payments for the services billed

Medicare patients

91

Average age 74

Services billed

3,621

49 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Chronic kidney disease 55%
Ischemic heart disease 54%
Diabetes 53%
Depression 51%
Heart failure 49%
Atrial fibrillation 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record